Stock Events

Vistin Pharma ASA 

kr26
6
+kr2+8.33% Friday 14:25

Statistics

Day High
26.9
Day Low
24.1
52W High
-
52W Low
-
Volume
265,622
Avg. Volume
-
Mkt Cap
1.03B
P/E Ratio
15.06
Dividend Yield
1.92%
Dividend
0.5

Upcoming

6
NOV
Dividend Ex
 
19
NOV
Dividend Payment
 
6
NOV 25
Dividend Ex
Estimated
 
19
NOV 25
Dividend Payment
Estimated
 
6
NOV 26
Dividend Ex
Estimated
 
19
NOV 26
Dividend Payment
Estimated
 

Dividends

1.92%Dividend Yield
Jun 24
kr0.5
Jan 24
kr0.75
Jun 21
kr0.5
Jun 20
kr1
Nov 17
kr7
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
51.83%
1Y Growth
N/A

Earnings

23MayExpected
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-0.15
0.18
0.52
0.85
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow VISTN.OL. It's not an investment recommendation.
Alphabet
73387
GOOGL
Apple
64075
AAPL
Microsoft
59714
MSFT
Amazon
55119
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novo Nordisk
NVO
Mkt Cap620.4B
Novo Nordisk is a global healthcare company with more than 95 years of innovation and leadership in diabetes care. This competes directly with Vistin Pharma's focus on pharmaceuticals and medical solutions.
Pfizer
PFE
Mkt Cap164.39B
Pfizer is a global biopharmaceutical company that produces medicines and vaccines for a wide range of medical disciplines, including areas where Vistin Pharma operates.
Merck
MRK
Mkt Cap300.25B
Merck & Co., Inc. provides healthcare solutions that include pharmaceutical, vaccines, biologic therapies, and animal health products, competing in the pharmaceuticals sector with Vistin Pharma.
Astrazeneca
AZN
Mkt Cap271.67B
AstraZeneca is a multinational pharmaceutical and biopharmaceutical company with a wide range of products in various therapeutic areas, competing with Vistin Pharma in the pharmaceutical market.
GSK
GSK
Mkt Cap89.55B
GlaxoSmithKline is a global healthcare company that researches, develops, and manufactures innovative pharmaceutical medicines, vaccines, and consumer healthcare products, competing with Vistin Pharma.
Johnson & Johnson
JNJ
Mkt Cap399.26B
Johnson & Johnson is a multinational corporation that produces pharmaceuticals, medical devices, and consumer packaged goods, directly competing with Vistin Pharma in the healthcare sector.
Sanofi
SNY
Mkt Cap141.43B
Sanofi is a global biopharmaceutical company focused on human health, offering a broad range of medicines and vaccines, which puts it in competition with Vistin Pharma.
Abbvie
ABBV
Mkt Cap346.75B
AbbVie is a research-based biopharmaceutical company that develops and markets advanced therapies, competing with Vistin Pharma in the pharmaceutical and healthcare market.
Bristol-Myers Squibb
BMY
Mkt Cap101.27B
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases, competing with Vistin Pharma.
Novartis
NVS
Mkt Cap244.75B
Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide, competing with Vistin Pharma in various therapeutic areas.

About

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. Vistin Pharma ASA was founded in 1969 and is headquartered in Oslo, Norway.
Show more...
CEO
Mr. Magnus Tolleshaug
Employees
73
Country
NO
ISIN
NO0010734122

Listings

OL
NO
VISTN.OL
LSE
GB
0RAM.LSE
F
DE
VP4.F